COVID-19 vaccine manufacturers are expected to produce 12 billion doses by the end of the year – almost half made by China – and there could be a vaccine surplus by mid-next year. In addition, by the end of this month, around 500 million doses should be ready for “redistribution” from wealthy to low-and middle-income … Continue reading Massive Increase in COVID-19 Vaccine Production May Mean Dose Surplus by Mid-2022, says IFPMA